Issue 9, 2022

Lab on a chip devices for fertility: from proof-of-concept to clinical impact

Abstract

Microfluidics offers tremendous opportunities to understand the underlying biology of fertilization at the single-cell level and improve infertility management, however, its true clinical impact is yet to be realized. Lab-on-a-chip devices have generally failed to diffuse into clinical practice due to issues associated with their translation or their practicality and performance in clinical settings. In this perspective, I reflect on how the full potential of microfluidic technologies for fertility can be realized by considering regulatory and manufacturing considerations at the development stage and by redefining our developmental goals to directly target the ultimate clinical needs. I also challenge the common rationale around developing technologies for infertility treatment based on reducing cost and complexity in operation as the ultimate outcome is invaluable, human life.

Graphical abstract: Lab on a chip devices for fertility: from proof-of-concept to clinical impact

Article information

Article type
Perspective
Submitted
13 جمادى الأولى 1443
Accepted
05 رمضان 1443
First published
06 رمضان 1443

Lab Chip, 2022,22, 1680-1689

Lab on a chip devices for fertility: from proof-of-concept to clinical impact

R. Nosrati, Lab Chip, 2022, 22, 1680 DOI: 10.1039/D1LC01144H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements